Acetylation of Histone H3 in Cancer Progression and Prognosis
View abstract on PubMed
Summary
This summary is machine-generated.Histone acetylation, an epigenetic change, is linked to cancer development. Aberrant acetylation of histone H3 may serve as a crucial biomarker for cancer prognosis and patient outcomes.
Area Of Science
- Oncology
- Epigenetics
- Molecular Biology
Background
- Cancer arises from genetic and epigenetic alterations.
- Histone acetylation, a key epigenetic mechanism, influences gene expression and chromatin structure.
- Altered histone acetylation is implicated in cancer initiation, progression, and tumor aggressiveness.
Purpose Of The Study
- To review recent findings on histone H3 acetylation in cancer biology.
- To highlight the potential of H3 acetylation as a cancer biomarker.
- To discuss the prognostic implications of H3 acetylation levels.
Main Methods
- Review of current literature on histone H3 acetylation in various cancer types.
- Analysis of the association between H3 acetylation patterns and cancer progression.
- Evaluation of H3 acetylation as a prognostic indicator.
Main Results
- Histone acetylation, particularly of histone H3, is frequently dysregulated in cancer.
- Specific acetylation patterns of histone H3 residues correlate with different cancer types.
- Aberrant global histone acetylation levels are linked to tumor aggressiveness.
Conclusions
- Histone H3 acetylation is a significant epigenetic modification in cancer.
- Specific H3 acetylation sites may serve as valuable biomarkers for cancer diagnosis and prognosis.
- Further research into H3 acetylation could lead to novel therapeutic strategies.
Related Concept Videos
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

